The recent news focuses on the globally significant collaboration between India and the U.S. in vaccine research and testing for Covid-19. As nations across the world grapple with the pandemic, joint efforts for a solution have become more crucial than ever. This article explores the key highlights of this collaboration.
Vaccine Action Programme (VAP)
In response to the ongoing global health crisis, partners under the Vaccine Action Programme (VAP) have decided to come together to expedite the development and testing of potential vaccines and diagnostic tools for Covid-19. The Indo-U.S. Vaccine Action Program is a long-standing partnership of 33 years between the Indian Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), the U.S. National Institutes of Health and other relevant partners.
The primary aim of this joint program is to produce safe, cost-effective vaccines targeting a wide spectrum of infectious diseases. The joint venture has garnered international attention in hopes that it will facilitate the accelerated production of a vaccine against the novel coronavirus.
Other Collaborative Initiatives
Apart from the VAP, there are several other initiatives undertaken jointly by India and the U.S. in order to fight against Covid-19. The U.S. President had previously announced the donation of 200 ventilators to India, 50 of which will be arriving shortly. This act of solidarity is being funded by the U.S. Agency for International Development (USAID).
In addition, USAID has declared funding of $5.9 million for India till date with the aim of supporting the country’s battle against the deadly virus. The aid provides a much-needed boost for India in its endeavor to enhance healthcare facilities and infrastructure.
Additional Funding from U.S. Centres for Disease Control and Prevention
Further augmenting the financial aid, the U.S. Centres for Disease Control and Prevention (CDC) have committed funds of $3.6 million to the Government of India. This funding is earmarked to support various tasks such as prevention, preparedness, and response activities in India. This venture by the CDC will be carried out in collaboration with, and concurrence from the Government of India.
India’s Export of Hydroxychloroquine (HCQ)
In addition to the collaborative efforts in the field of research, testing, and healthcare aid, India has been active in the export of the antimalarial drug, Hydroxychloroquine (HCQ). The U.S. along with several other countries have received this drug from India. Although the efficacy of HCQ in treating Covid-19 is still under investigation, its demand has seen a significant increase due to the ongoing pandemic.
The collaboration between India and the U.S., amidst the global health crisis, stands testimony to the international unity in the strive towards a solution. Through joint research initiatives, financial aid, and healthcare assistance, these nations are working together in their fight against Covid-19. Their united effort represents an important milestone in the global effort towards containing and eventually eliminating this deadly virus.
